In conversation with...

Professor Valery Feigin discusses an Article on the global burden of stroke and risk factors from 1990–2013.

Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.

Richard Lane interviews John Hardy, Jonathan Rohrer and Sarah Tabrizi, who are members of the Scientific Committee.

Francesc Graus and Josep Dalmau discuss new criteria for a clinical approach for the diagnosis of autoimmune encephalitis.

Rustam Salman discusses how the assessment of cerebral cavernous malformations can help identify people at risk of subsequent brain haemorrhage.

Bas Bloem talks about ParkinsonNet, a healthcare model that supports a multidisciplinary network for people with Parkinson’s disease.

Clifford Jack from the Mayo Clinic discusses a research article which investigates the role of biomarkers to help identify preclinical dementia.

Chris McDermott and Richard Lane discuss the DiPALS study, investigating the effect of diaphragm pacing in addition to non-invasive ventilation in patients with ALS.

Bruce Campbell discusses the remarkable benefits of endovascular treatment for ischaemic stroke.

Jalesh Panicker discusses lower urinary tract dysfunction, a common problem in people with neurological disorders.